AT443075T

Hcv ns3 protease inhibitors

Abstract

A compound of formula (I): wherein: the ipiq 1; R 1 is CONR10SO2R6; R2 is C1-C6 alkyl or C2-C6 alkenyl, wherein said alkyl or alkenyl optionally substituted with 1 to 3 halo; R 3 is C 1 -C 8 alkyl or C3-C8 cycloalkyl; R5 is H; R6 is C3-C6 cycloalkyl, Y is C (= 0); Z is O; M is C1-C12 alkylene or C2-C12 alkenylene; each entry R10 is independently H or C1-C6 alkyl; or a pharmaceutically acceptable salt or hidrat.Prijava contains 16 claims.

Term

No projected expiry on record.

57 members in 34 offices

This recordMember, by publication datePriority claim24 more offices are in the list below

Priority claims3

Priority claims
Document	Office	Kind	Date
70076405	United States of America	P	2005-07-20
72456605	United States of America	P	2005-10-07
2006027573	United States of America	W	2006-07-14

Members57

Family members, oldest first
Document	Office	Kind
US2007027071A1	United States of America	A1	2007-02-01
AU2006276189A1	Australia	A1	2007-02-08
CA2615022A1	Canada	A1	2007-02-08
WO2007015787A1	World Intellectual Property Organization (WIPO)	A1	2007-02-08
WO2007015855A1	World Intellectual Property Organization (WIPO)	A1	2007-02-08
TW200740850A	Taiwan Province of China	A	2007-11-01
AR057456A1	Argentina	A1	2007-12-05
CR9621A	Costa Rica	A	2008-02-21
MX2008000866A	Mexico	A	2008-03-18
KR20080027860A	Republic of Korea	A	2008-03-28
IL188618A0	Israel	A0	2008-04-13
EP1910404A1	European Patent Office (EPO)	A1	2008-04-16
NO20080879L	Norway	L	2008-04-17
EP1924593A1	European Patent Office (EPO)	A1	2008-05-28
EA200800371A1	Eurasian Patent Organization (EAPO)	A1	2008-06-30
CN101228181A	China	A	2008-07-23
US7470664B2	United States of America	B2	2008-12-30
JP2009502793A	Japan	A	2009-01-29
MA30198B1	Morocco	B1	2009-02-02
HK1121169A1	Hong Kong, China	A1	2009-04-17
US2009124661A1	United States of America	A1	2009-05-14
TNSN08033A1	Tunisia	A1	2009-07-14
EP1924593B1	European Patent Office (EPO)	B1	2009-09-16
AT443075TThis record	Austria	T	2009-10-15
ATE443075T1	Austria	T1	2009-10-15
DE602006009280D1	Germany	D1	2009-10-29
EP1924593B8	European Patent Office (EPO)	B8	2009-11-18
PT1924593E	Portugal	E	2009-12-07
DK1924593T3	Denmark	T3	2010-01-25
HRP20090627T1	Croatia	T1	2010-01-31
ES2332821T3	Spain	T3	2010-02-12
PL1924593T3	Poland	T3	2010-02-26
EA013331B1	Eurasian Patent Organization (EAPO)	B1	2010-04-30
SI1924593T1	Slovenia	T1	2010-04-30
EP1924593B9	European Patent Office (EPO)	B9	2010-06-02
UA90909C2	Ukraine	C2	2010-06-10
ZA200800072B	South Africa	B	2010-06-30
SG164376A1	Singapore	A1	2010-09-29
NZ565223A	New Zealand	A	2010-09-30
RS51101B	Serbia	B	2010-10-31
MY142240A	Malaysia	A	2010-11-15
BRPI0613633A2	Brazil	A2	2011-01-18
JP4621282B2	Japan	B2	2011-01-26
JP2011079828A	Japan	A	2011-04-21
GEP20115248B	Georgia	B	2011-07-11
AU2006276189B2	Australia	B2	2011-10-13
AU2006276189B9	Australia	B9	2012-02-02
US8216999B2	United States of America	B2	2012-07-10
CA2615022C	Canada	C	2012-09-04
TWI387603B	Taiwan Province of China	B	2013-03-01
KR101296095B1	Republic of Korea	B1	2013-08-20
CN101228181B	China	B	2013-09-18
JP5345117B2	Japan	B2	2013-11-20
EP1910404B1	European Patent Office (EPO)	B1	2013-11-27
ES2446015T3	Spain	T3	2014-03-06
EP1910404B9	European Patent Office (EPO)	B9	2014-05-21
ES2446015T9	Spain	T9	2014-07-16

2 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2010-11-15	Change of the company nameEEFA	EEFA
2010-03-15	Publication of translation of european patent specificationUEP	UEP